2 Exceptional Growth Stocks to Buy Before the Next Bull Market
No matter how tough it can be to hold onto your investments when they are losing value during bear markets, they always end, and bull markets are liable to kick off shortly thereafter. In fact, investors who keep buying shares of quality companies when the mood on Wall Street is sour are the ones who tend to get a lot richer when it turns. If you want to be one of them, now's the time to be buying.
In my view, there are a couple of exceptionally strong growth stocks that are particularly worth considering right now. Both companies have upcoming or ongoing catalysts that should lead to their making more money tomorrow than they do today -- and both are likely to continue winning in the long term.
The reason AbbVie (NYSE: ABBV) is worth purchasing before the next bull market is that its valuation is a decent bargain relative to other businesses in the pharmaceutical industry. Its price-to-sales (P/S) ratio is 4.6, and its price-to-earnings (P/E) ratio is 22.9. In contrast, the pharma industry's average P/S is 5.1, and its average P/E is 24.6. That means you should get a bit more bang for your buck with AbbVie's shares than with shares of one of its competitors.
Source Fool.com